SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
International journal of molecular sciences, 2017-05, Vol.18 (5), p.1083 [Peer Reviewed Journal]Copyright MDPI AG 2017 ;2017 by the authors. 2017 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms18051083 ;PMID: 28524098
Full text available